Drugs / DTX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05116891 Background | Sep 2021 → Jun 2023 | biliary tract cancer, colorectal cancer, non-small cell lung carcinoma | Cantargia AB | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05116891 ↗ |